Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Response

Clin Cancer Res. 2023 Mar 14;29(6):1158-1159. doi: 10.1158/1078-0432.CCR-23-0164.
No abstract available

Publication types

  • Comment

MeSH terms

  • DNA Repair
  • Female
  • Humans
  • Mutation
  • Neoplasms* / drug therapy
  • Neoplasms, Second Primary* / drug therapy
  • Ovarian Neoplasms*
  • Poly(ADP-ribose) Polymerase Inhibitors / adverse effects

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors